RGEN — Repligen Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Repligen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	59.9	128	186	41.6	-25.5
Depreciation
Deferred Taxes
Non-Cash Items	28.2	47.9	0.302	10.6	70.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-48.6	-102	-63.8	-8.64	60.9
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	62.6	119	172	114	175
Capital Expenditures	-26.3	-71.3	-88.3	-39	-29.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-175	-150	-145	-84.3	-56.5
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities	-201	-221	-233	-123	-86.4
Financing Cash Flow Items	-0.01	-2.9	-17	-27.8	-17.3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	306	0.961	-13.3	249	-82.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	180	-113	-80.4	228	6.03